SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-18-195773
Filing Date
2018-06-18
Accepted
2018-06-18 17:09:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D AMENDMENT NO. 2 d611018dsc13da.htm SC 13D/A 39263
  Complete submission text file 0001193125-18-195773.txt   41093
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Subject) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-51051 | Film No.: 18905328
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 3 AVENUE DES TROPIQUES LES ULIS COURTABOEUF I0 91958
Business Address 3 AVENUE DES TROPIQUES LES ULIS COURTABOEUF I0 91958 33 6 33554531
LFB Biotechnologies S.A.S.U. (Filed by) CIK: 0001377942 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D/A